Chardan's Take On Axovant, Avalanche & VistaGen
July 27, 2015 at 12:47 PM EDT
A new report out this week by Chardan Capital Management focuses on three biotech stocks that the firm has been watching lately. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.